EPISKIN will present new poster in collaboration with La Roche-Posay during the Journées Dermatologiques de Paris (JDP) Virtual Congress that will be held from December 1st to 5th 2020.
First glance at the poster:
USE OF RECONSTRUCTED SKIN MODEL TO ASSESS THE PHOTO-PROTECTION AFFORDED BY SUNSCREEN PRODUCTS AGAINST DNA LESIONS AND CELLULAR ALTERATIONS
D. LELIEVRE(1), F. CANIVET(1), F. THILLOU(1), C. TRICAUD(2), C. LE FLOC’H(3), F. BERNERD(4)
(1)Episkin, Lyon, France - (2)L’Oréal R&I, Chevilly-Larue, France - (3) La Roche-Posay Dermatological Laboratories, Levallois-Perret, France - (4)L’Oréal R&I, Aulnay sous Bois, France
Protecting the skin from the solar UV rays is a public health issue. Both UVB and UVA rays induce multiple damages in the epidermis and the dermis that contribute to photo-carcinogenesis and photoageing. Sunscreen products are effective to prevent these deleterious effects. In the present study, the photoprotection afforded by 2 commercial sunscreen products (Anthelios 50+ (La Roche-Posay) and formulation B), and 2 ISO sunscreens standard P3 (SPF15) & P6 (SPF40) was analyzed and compared regarding UV Solar Simulated Radiation (UVSSR) -induced damages on reconstructed skin tissues. The photoprotective potential against UVSSR exposure was evaluated according to several biological parameters, including DNA lesions.
To discover more about our poster or JDP congress please follow this link : www.lesjdp.fr/